liver injury and inflammation come from an elevation in hepatic activities of urokinase-type plasminogen activator, and activation of hepatocyte growth factor receptor c-Met. 10 Hepatocytes apoptosis plays an important role in the pathogenesis of cholestatic liver injury. An in vitro study reported that metformin dose-dependently reduces bile acid glycochenodeoxycholic acid (GCDCA)-induced hepatocyte apoptosis. 11 This study reported that the AMPK-independent protective effect of metformin is mainly dependent on an intact PI3-kinase pathway in GCDCA-exposed hepatocytes.
11
Although the hepatic PAI-1 signals were not evaluated in BDL-cirrhotic rats, both hepatic PAI-1 and PI3-kinase pathways are crucial for the beneficial effects of chronic metformin treatment in cirrhotic rats. 5 This study is characterized by the use of a well-established animal model of intrapulmonary vasodilatation and macrophage infiltration in BDL-cirrhotic rats with HPS. 5, 12 The dose and duration of metformin use in this study suppress the pulmonary COX-1 expression and intrapulmonary shunt amount. 5 The lack of chronic metformin treatment on pulmonary angiogenesis of cirrhotic rats might be due to the complication anti-angiogenesis and pro-angiogenesis of metformin. 13, 14 Taking into consideration the complicated and multifaceted pathogenesis of cirrhotic HPS, more than one therapeutic strategy may be necessary to effectively improve hepatic fibrosis, cirrhosis as well as HPS.
In patients with diabetes, continuation of metformin use after the diagnosis of cirrhosis significantly improved survival durations. 15 Overall, this study first established the mechanism and effects of chronic metformin treatment in cirrhotic rats with dual organ beneficial effects. On the other hand, this study also reported that it is safe to use metformin in cirrhotic animals with glucose intolerance and mild renal impairment.
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